What does GYNOB - B.D. do?

GYNOB - B.D. is a specialist medical practice in Sint-Jans-Molenbeek. Private Limited, started on 30 October 1998, 1 establishment.

What is the address of GYNOB - B.D.?

The registered office of GYNOB - B.D. is located at Vrijheidslaan 191, 1080 Sint-Jans-Molenbeek.

Is GYNOB - B.D. still active?

Yes. According to the CBE (30 October 2026) GYNOB - B.D. is active, legal situation “Normale toestand”, started on 30 October 1998.

Is GYNOB - B.D. registered on Peppol?

No, GYNOB - B.D. is currently not registered on the Peppol network.

What is the enterprise number of GYNOB - B.D.?

The enterprise number of GYNOB - B.D. is BE0464481431.

When was GYNOB - B.D. founded?

GYNOB - B.D. was founded on 30 October 1998.

Who are the directors of GYNOB - B.D.?

According to the 2025 annual accounts, the directors of GYNOB - B.D. are: Nathalie DERNY, PAUL BEFAHY.

Is GYNOB - B.D. a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 October 1998; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did GYNOB - B.D. make in 2025?

GYNOB - B.D. posted a profit after taxes of € 464 in financial year 2025.

What is the revenue of GYNOB - B.D.?

In its most recent annual accounts (2025), GYNOB - B.D. reported revenue of € 631,235.

How much does an employee at GYNOB - B.D. earn?

The average wage cost per full-time employee at GYNOB - B.D. was € 70,900 in 2025: staff costs of € 85,070 for 1.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does GYNOB - B.D. have?

According to the 2025 annual accounts, GYNOB - B.D. has 1.2 full-time equivalents (FTE).

GYNOB - B.D. (Private Limited) - Sint-Jans-Molenbeek

Dossier GYNOB - B.D., printed on 30 October 2026 from databakkes.be/en/0464481431/gynob-b-d. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

GYNOB - B.D. from Sint-Jans-Molenbeek, company number BE0464481431, closed financial year 2025 with a result of € 464 after tax. For that financial year GYNOB - B.D. recorded revenue of € 631,235 and equity of € 27,928. Compared with financial year 2024, the result moved from € 1,315 to € 464. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 27,928

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 464

▼ 65% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 48,256

▼ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 21,723.

People and assets in 2025

Full-time equivalents

1.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 85,070

▲ 13% vs 2024

€ 70,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 15,960

▲ € 14,451 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 48,833

▼ 22% vs 2024

€ 13,365 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 28,195

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 9,924

▲ 31% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	-	€ 631,235 Revenue 2025: € 631,235 First fiscal year in the series
Gross margin	€ 85,993 Gross margin 2022: € 85,993 First fiscal year in the series	€ 80,603 Gross margin 2023: € 80,603 ▼ 6% vs 2022 (€ 85,993) Unfavourable step	€ 91,631 Gross margin 2024: € 91,631 ▲ 14% vs 2023 (€ 80,603) Favourable step	€ 104,959 Gross margin 2025: € 104,959 ▲ 15% vs 2024 (€ 91,631) Favourable step	▲ 15%
Profit after taxes	€ -305 Profit after taxes 2022: € -305 First fiscal year in the series	€ 213 Profit after taxes 2023: € 213 ▲ € 517 vs 2022 (€ -305) Favourable step	€ 1,315 Profit after taxes 2024: € 1,315 ▲ € 1,102 vs 2023 (€ 213) Favourable step	€ 464 Profit after taxes 2025: € 464 ▼ 65% vs 2024 (€ 1,315) Unfavourable step	▼ 65%
Equity	€ 25,936 Equity 2022: € 25,936 First fiscal year in the series	€ 26,149 Equity 2023: € 26,149 ▲ 1% vs 2022 (€ 25,936) Favourable step	€ 27,464 Equity 2024: € 27,464 ▲ 5% vs 2023 (€ 26,149) Favourable step	€ 27,928 Equity 2025: € 27,928 ▲ 2% vs 2024 (€ 27,464) Favourable step	▲ 2%
Total debts	€ 672,987 Total debts 2022: € 672,987 First fiscal year in the series	€ 293,117 Total debts 2023: € 293,117 ▼ 56% vs 2022 (€ 672,987) Favourable step	€ 271,343 Total debts 2024: € 271,343 ▼ 7% vs 2023 (€ 293,117) Favourable step	€ 215,819 Total debts 2025: € 215,819 ▼ 20% vs 2024 (€ 271,343) Favourable step	▼ 20%
Cash	€ 577,716 Cash 2022: € 577,716 First fiscal year in the series	€ 179,463 Cash 2023: € 179,463 ▼ 69% vs 2022 (€ 577,716) Unfavourable step	€ 91,317 Cash 2024: € 91,317 ▼ 49% vs 2023 (€ 179,463) Unfavourable step	€ 48,256 Cash 2025: € 48,256 ▼ 47% vs 2024 (€ 91,317) Unfavourable step	▼ 47%
Retained profit	€ 19,731 Retained profit 2022: € 19,731 First fiscal year in the series	€ 19,944 Retained profit 2023: € 19,944 ▲ 1% vs 2022 (€ 19,731) Favourable step	€ 21,259 Retained profit 2024: € 21,259 ▲ 7% vs 2023 (€ 19,944) Favourable step	€ 21,723 Retained profit 2025: € 21,723 ▲ 2% vs 2024 (€ 21,259) Favourable step	▲ 2%
Bank debt	€ 2,748 Bank debt 2022: € 2,748 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 2,748) Favourable step	€ 62,468 Bank debt 2024: € 62,468 Unchanged (€ 0) Unfavourable step	€ 48,833 Bank debt 2025: € 48,833 ▼ 22% vs 2024 (€ 62,468) Favourable step	▼ 22%
Balance sheet total	€ 698,923 Balance sheet total 2022: € 698,923 First fiscal year in the series	€ 319,265 Balance sheet total 2023: € 319,265 ▼ 54% vs 2022 (€ 698,923) Unchanged	€ 298,808 Balance sheet total 2024: € 298,808 ▼ 6% vs 2023 (€ 319,265) Unchanged	€ 243,747 Balance sheet total 2025: € 243,747 ▼ 18% vs 2024 (€ 298,808) Unchanged	▼ 18%
Employees (FTE)	1.2 Employees (FTE) 2022: 1.2 First fiscal year in the series	1.2 Employees (FTE) 2023: 1.2 Unchanged (1.2) Unchanged	1.2 Employees (FTE) 2024: 1.2 Unchanged (1.2) Unchanged	1.2 Employees (FTE) 2025: 1.2 Unchanged (1.2) Unchanged

Key figures of GYNOB - B.D., fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GYNOB - B.D.?

What happened at GYNOB - B.D. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 464 (▼ 65% vs 2024). Source: NBB ↗
2026 Nathalie DERNY became a director. NBB
2026 PAUL BEFAHY stepped down as director. NBB
Jan 19, 2003 New establishment in Sint-Jans-Molenbeek. KBO
Oct 30, 1998 Start of the company according to the CBE. KBO

In short

From € 305 loss in 2022 to € 464 profit in 2025.

Paid € 1,559 in corporate taxes since 2022.

Best year ever: 2024, with € 1,315 profit.

On average € 87,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

OBGYN 34%

Dr. Michèle Lievens 33%

The stake of OBGYN, Dr. Michèle Lievens comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

GYNOB - B.D.

Behind GYNOB - B.D. is Nathalie DERNY. The shares are held by OBGYN (34%) and Dr. Michèle Lievens (33%).

Directors

According to the 2025 annual accounts

Nathalie DERNY

Director

Also active at: Centre Hospitalier Interrégional Edith Cavell - Les Hôpitaux de Braine-l'Alleud - Waterloo, de Delta et de Sainte-Anne Saint-Remi; les Cliniques de la Basilique et Edith Cavell, les Centres..., NATHALIE DERNY

since 2026

PAUL BEFAHY

Director

· until 2026

Shareholders

OBGYN

34%

Dr. Michèle Lievens

33%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Vrijheidslaan 191

1080 Sint-Jans-Molenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0464.481.431

VAT number

BE 0464.481.431

Registered office

Vrijheidslaan 191, 1080 Sint-Jans-Molenbeek

Names & denominations

GYNOB - B.D.

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 October 1998

Peppol

Not registered

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

GYNOB - B.D.

Warning lights

Financials

What happened to GYNOB - B.D.?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions